Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H15NO4 |
| Molecular Weight | 309.316 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(OC(=O)C2=CC=C(N)C=C2)C(O)=C3C=CC=CC3=C1O
InChI
InChIKey=YLMPBJUYFTWHKJ-UHFFFAOYSA-N
InChI=1S/C18H15NO4/c1-10-15(20)13-4-2-3-5-14(13)16(21)17(10)23-18(22)11-6-8-12(19)9-7-11/h2-9,20-21H,19H2,1H3
Aminaphtone, a synthetic molecule derived from 4-aminobenzoic acid, is a drug affecting vessel functioning. Aminaphtone significantly protects endothelium permeability and stabilises endothelial cells organised in capillary-like structures, modulating VE-cadherin expression. In addition aminaphtone modulate expression of several inflammatory and vasoactive factors. Aminaphtone (Capilarema) is used in the treatment of vascular disorders, especially chronic venous disease.
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27083548
ECV-304 endothelial cells were stimulated with IL-1β 100U/ml in the presence or absence of Aminaphtone 6 μg/ml
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID00163725
Created by
admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
|
PRIMARY | |||
|
SUB12847MIG
Created by
admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
|
PRIMARY | |||
|
238-809-8
Created by
admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
|
PRIMARY | |||
|
14748-94-8
Created by
admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
|
PRIMARY | |||
|
46276
Created by
admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
|
PRIMARY | RxNorm | ||
|
100000077685
Created by
admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
|
PRIMARY | |||
|
03JLX11PE9
Created by
admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
|
PRIMARY | |||
|
DB13039
Created by
admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
|
PRIMARY | |||
|
159
Created by
admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
|
PRIMARY | |||
|
84621
Created by
admin on Mon Mar 31 19:31:26 GMT 2025 , Edited by admin on Mon Mar 31 19:31:26 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD